Search results for " cell" in Articles / App Notes
Article
Continued Process Verification for Biopharma Manufacturing
Its recommendations are based on a typical cell culture production process for making a fictitious monoclonal antibody (mAb) product (3). Although this model plan does not provide examples of all aspe…
Article
Pharma Investments Reflect Key Industry Trends
According to the company, it now has a more focused portfolio with depth in dermatology, heart failure, respiratory, cell therapy, and oncology in its pharmaceuticals business, a strong position in ey…
Article
Concentration and Diafiltration of Cell-Derived, Live Influenza Virus Using 750 C Hollow Fiber Filter Cartridge
Cross flow filtration (CFF) is a technique extensively used in vaccine production and particularly in influenza vaccine manufacturing. In contrast to normal flow (dead-end) filtration (NFF), the fee…
Article
Single-Use and Continuous Processing Technologies Change Facility Design
With no waiting for cell growth and cell-culture bioreactors continuously operating, columns can be smaller than when they need to handle whole fermenter volumes at one time. Ultimately, the whole fac…
Article
Defining Critical Quality Attributes for Monoclonal Antibody Therapeutic Products
Otherwise, cell culture, purification, and drug product development may put undue importance on meeting certain criteria that are ultimately not critical, resulting in suboptimal processes that make u…
Article
Q&A with Industry Leader Konstantin Konstantinov, Genzyme Vice-President
But with continuous processing, once the protein is secreted from the cells it can be taken out of the bioreactor and purified immediately, so there’s no degradation.
Up until a few years ag…
Article
Monoclonal Antibodies Key to Unlocking the Biosimilars Market
The European Medicines Agency (EMA) approved the first mAb biosimilar developed by Celltrion and Hospira in 2013 (infliximab: Remsima/Inflectra). Development of clear, regulatory approval pathways for…
Article
Biopharma Outsourcing Activities Update
This increased outsourcing is also the case for areas such as cell line development and downstream process development.
Moreover, expectations surrounding future levels of outsourcing activity rema…
Article
Q&A with Industry Leaders: Rita Peters
One example is Cytiva’s acquisition of the HyClone line cell culture media, sera, and process liquids; Dharmacon RNAi gene modulation, products; and Sera-Mag magnetic beads. With the changes in compan…
Article
EMA Collaborates with HTA Assessment Networks
Belgium, a cell-therapy specialist, has achieved reimbursement deals for the product in only three European countries--Belgium, Netherlands, and Spain, all of which it has facilities in.
“Gaining r…